during the period 1960-71 are presented and compared with an earlier series treated in the period 1947 -50. It is estimated that about 29°, of the patients treated in the later period are cured, in the sense that they have a life expectancy similar to that of the normal population, compared with just under 20% in the earlier period, but this improvement is mainly due to an increased proportion of Stage I cases in the later period. The percentage cured is discussed in relation to the ratio of deaths to registrations in the East Anglian Region and it is suggested that under-registration of deaths from cancer of the breast may occur.
AT THE END of the 1950s Dr Diana Brinkley and I carried out a study on the results of treatment of 704 patients with female breast cancer seen in the Cambridgeshire Area from 1947 to 1950 (Brinkley & Haybittle, 1959) . The longterm follow-up of this series (Brinkley & 1-laybittle, 1975) suggested that just under 20% of all patients were cured in the sense that they had a life expectancy similar to that of the normal population. Nevertheless, although the death rate in the series between 20 and 25 years was almost the same as that of a normal population, 8/23 deaths after 20 years were from cancer of the breast, which is about 16 x the number that would be expected from canicer of the breast in the normal population. No cancer registry was operating in the Cambridge area at the time when the patients were treated and, although we endeavoured to collect as representative a group as possible of breast-cancer patients, we were aware that the series was probably deficient in operable cases treated by surgery only, and also perhaps in late Stage IV cases who were never referred anywhere for treatment. tion in this area, the dotted line in Fig. I shows there has also been a real increase in incidence per 100,000 females. Obviously the registrations in any one year give rise to deaths in later years, so that to get an idea of the success rate from these figures, it is more sensible to compare the deaths with the registrations at an earlier period. This is done in Table I   TABLE I Fig. 7 .
Another change in the staging between the 2 series is in the effect of supraclavicular nodes. In the older series their presence placed a patient in Stage IV, whilst in the 1960-71 series a supraclavicular node placed a patient in Stage III. This would tend to improve results in Stage IV in the earlier series and this also is apparent in Fig. 7 .
The cured group of 1960-71 patients A comparison of the stage distribution in the 2 series is shown in Fig. 8 , where the most apparent difference is the higher number of unstaged cases in the earlier series. The majority of these were operated on, but the clinical findings before mastres for ectomy were inadequately recorded for when staging purposes. Their survival rates were very similar to those of the Stage II cases in the same series (Brinkley & by stage Haybittle, 1959) . ppears in If we make the comparison with the unignificant staged cases excluded (Fig. 9) we can see '>0 005) that the later series has a higher propor3s.
tion of Stage I cases and a lower proporat policy tion of Stages II and IV. The differences riods was in II's and IV's must to sonme extent be her than accounted for by the changes in staging ry treat-already mentioned, but the differences in be postu-I's is probably a genuine effect due to the (Brinkley & Haybittle, 1968) compared with the 18°/ figure estimated by the model after a much longer follow-up (Brinkley & Haybittle, 1975) .
The estimate of 29% cured in the 1960-71 series goes a long way towards explaining the anomaly of the deaths/registrations ratio mentioned at the beginning of this paper. If one-tenth of the uncured group die from other causes this would leave at least 63°/ of the total group dying from cancer of the breast, although this figure would be increased by any excess deaths from cancer of the breast in the "cured" group. The ratio of deaths to registrations 5 years previously was about 61% (Table   I ) which is still lower than the percentage predicted from the cured group analysis, but perhaps not unreasonable in view of the inaccuracies of death certification. It does, however, require that such inaccuracies, if they exist, should lead to under-registration of deaths from cancer of the breast, rather than to over-registration.
I am very much indebted to Dr E. AM. KingsleyPillers, Director of the Cambridge Cancer Registration Bureau, for allowing me access to the data for the 1960-71 period, and to Dr Diana Brinkley for first drawing my attention to the ratio of (leaths to registrations in the national figures.
